8C5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coherus BioSciences Inc

Watchlist Manager

Watchlist

Price: 1.245 EUR 3.41% Market Closed

Market Cap: €142.8m

C	Coherus BioSciences Inc F:8C5	US
P	Prosegur Compania de Seguridad SA XBER:PRHA	ES
D	DXC Technology Co LSE:0I6U	US
T	TTL Beteiligungs und Grundbesitz AG XMUN:TTO	DE
	ArcelorMittal SA AEX:MT	LU
	Aedifica NV F:AOO	BE
	Euronet Worldwide Inc NASDAQ:EEFT	US
C	Carnival Corp DUS:CVC1	US
A	Aon PLC F:4VK	IE
	Thomson Reuters Corp NASDAQ:TRI	CA
D	DigitalOcean Holdings Inc DUS:0SU	US
L	Link Real Estate Investment Trust OTC:LKREF	HK
F	Famous Brands Ltd JSE:FBR	ZA
M	Morgan Stanley BMV:MS	US
	Clemondo Group AB (publ) F:N170	SE
P	Paccar Inc F:PAE	US

Profitability Summary

Coherus BioSciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

52%

Gross Margin is Increasing

50% > 67%

Negative Operating Margin

-410%

Negative 3Y Average Operating Margin

-173%

Declining Operating Margin

-126% > -410%

Exceptional Net Margin

398%

Strong 3Y Average Net Margin

35%

Net Margin is Increasing

-145% > 398%

Negative Free Cash Flow Margin

-328%

Negative 3Y Average Free Cash Flow Margin

-91%

Declining Free Cash Flow Margin

-135% > -328%

Negative ROE

-473%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-52%

Declining ROIC

-84% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.